Hormone Therapy and Young-Onset Breast Cancer

Estrogen plus progestin hormone therapy (HT) is associated with an increased risk of postmenopausal breast cancer, but few studies have examined the impact of HT use on the risk of breast cancer in younger women. We assessed the association between estrogen plus progestin HT or unopposed estrogen HT...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Epidemiol
Autori principali: O'Brien, Katie M., Fei, Chunyuan, Sandler, Dale P., Nichols, Hazel B., DeRoo, Lisa A., Weinberg, Clarice R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
Original Contributions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4423525/
https://ncbi.nlm.nih.gov/pubmed/25698646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwu347
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi